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Abstract
Background: Tremor is the most common movement disorder; however, the pathophysiology of tremor remains elusive. While several neuropathological
alterations in tremor disorders have been observed in post-mortem studies of human brains, a full understanding of the relationship between brain circuitry
alterations and tremor requires testing in animal models. Additionally, tremor animal models are critical for our understanding of tremor pathophysiology, and/or
to serve as a platform for therapy development.
Methods: A PubMed search was conducted in May 2018 to identify published papers for review.
Results: The methodology used in most studies on animal models of tremor lacks standardized measurement of tremor frequency and amplitude; instead, these
studies are based on the visual inspection of phenotypes, which may fail to delineate tremor from other movement disorders such as ataxia. Of the animal models
with extensive tremor characterization, harmaline-induced rodent tremor models provide an important framework showing that rhythmic and synchronous
neuronal activities within the olivocerebellar circuit can drive action tremor. In addition, dopamine-depleted monkey and mouse models may develop rest tremor,
highlighting the role of dopamine in rest tremor generation. Finally, other animal models of tremor have involvement of the cerebellar circuitry, leading to altered
Purkinje cell physiology.
Discussion: Both the cerebellum and the basal ganglia are likely to play a role in tremor generation. While the cerebellar circuitry can generate rhythmic
movements, the nigrostriatal system is likely to modulate the tremor circuit. Tremor disorders are heterogeneous in nature. Therefore, each animal model may
represent a subset of tremor disorders, which collectively can advance our understanding of tremor.
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Introduction
Tremor is the most common movement disorder phenomenology.
Tremor disorders are classified based on the predominant tremor
characteristics. Essential tremor (ET) is characterized by action tremor
in the upper extremities, whereas Parkinson’s disease (PD) tremor
classically presents as tremor at rest. Dystonic tremor (DT) is less
rhythmic and is usually associated with sustained muscle twisting.1,2
Other tremor disorders, including cerebellar outflow tremor, Holmes
tremor, and orthostatic tremor, are relatively rare. Despite some cli-
nical heterogeneity, one of the important aspects of tremor disorders is
the overlapping clinical features. For example, severe ET patients can
develop rest tremor, and severe PD patients can have action tremor.3
Many ET cases also have a dystonic component.4 While tremor
disorders are likely to be heterogeneous groups of diseases with pheno-
typical overlaps, the brain circuitry preferentially involved in the
generation of a specific type of tremor (action vs. rest vs. dystonic) is
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likely to share some commonalities with additional modulatory com-
ponents. Therefore, studies of animal models with different types of
tremor will likely lead to a comprehensive understanding of the
mechanism of diverse yet overlapping clinical features of tremor.
Based on neuroimaging studies5–7 and pathological studies8,9 in
patients, the cerebellum is involved in tremor generation. In addition,
magnetoencephalography and high-density electroencephalography
have shown that brain areas interconnected with the cerebellum or
further downstream regions, including the thalamus, motor and pre-
motor cortex, and part of the brainstem, may affect tremor expres-
sion.6,10 However, the mechanism by which structural alterations
within the brain circuit generate tremor remains unclear. Similarly, the
oscillatory neuronal activities are thought to be the physiological
correlates for tremor.11,12 Yet, it is unclear how the brain circuitry
alterations generate these rhythmic neuronal activities to drive tremor.
Thus, animal models are a useful tool to assess the relationship
between structural brain alterations, altered neuronal physiology, and
tremor. In addition, animal models of tremor may be a platform for
therapy development. Note that tremor is a terminology for movement
disorder that describes involuntary, rhythmic movements; therefore,
tremor is a symptom, rather than a disease. Thus, animal models of
tremor capture the symptoms of a disease, rather than reflect the
biological processes underlying the disease.
The present paper will first review the validated tremor animal
models with detailed clinical features (action tremor vs. rest tremor)
and the pharmacological responses of tremor in these models using
frequency-based measurement rather than merely visual observation.
We will also briefly review other animal models of tremor with varied
results. We will discuss how the pathophysiology learned from animal
models of tremor can help us to understand the controversies of
phenotypical overlaps of tremor disorders. Finally, we will attempt to
apply the knowledge of tremor pathophysiology learned from animal
models to explain some of the controversies in the tremor research
field.
Methods
A PubMed search was conducted in May 2018 using the term
‘‘tremor’’ in combination with the following search terms: ‘‘animal
models’’, ‘‘mouse’’, ‘‘rat’’, ‘‘monkey’’. In the initial screening, we
identified 1,171 articles; of these, 64 and 1,039 articles that were not
written in English and/or were irrelevant to the topic of this review,
respectively, were disregarded. Therefore, we selected 68 of the
remaining articles for this review. An additional five articles were
included based on the references. Thus, a total of 73 articles were
selected for this review (Table 1, Figure 1).
Based on the search results, we will first discuss the most widely
studied animal models for action tremor (harmaline-induced rodent
models) and rest tremor (dopamine-depleted monkey models) with
defined tremor frequency and characteristic measurement. We will next
discuss the animal models of tremor with frequency measurement but no
detailed action vs. rest tremor description. We will also review the current
literature for animal models of tremor without objective tremor mea-
surement; therefore, whether there is true tremor present in these animal
models will require further investigation. We will also review the tremor
pathophysiology in these animal models and how this knowledge should
advance our understanding of human tremor disorders.
Results
Animal models of action tremor
The classical animal model of action tremor is the harmaline-
induced model.13 A single dose of harmaline can induce action tremor by
enhancing the coupling between the inferior olivary (IO) neurons.14–17
The IO neurons have intrinsic subthreshold membrane potential
oscillations at 1–10 Hz, and harmaline exposure can result in enhanced
communications between IO neurons, which entrain the downstream
Purkinje cells (PCs) to fire synchronously and rhythmically at around
10–16 Hz via axons of the IO neurons called climbing fibers (CFs).14,15
Animals exposed to harmaline develop tremor at the same frequency.16,17
Table 1. Search Strategy
Key Words and Combination Number of Publications
Tremor AND Animal models Total Included Excluded
Tremor AND mouse 194 12 182 (not in English, 9; not relevant, 173)
Tremor AND rat 413 37 376 (not in English, 15; not relevant, 361)
Tremor AND monkey 470 15 455 (not in English, 31; not relevant, 424)
Total number of articles included for review 94 4 90 (not in English, 9; not relevant, 81)
Total number of articles included from the
references of the including articles
68
Final number of articles included for review 5
73
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During the tremor state, PCs fire rhythmic complex spikes, which
originate from CF excitatory synaptic transmission onto PCs with a
dramatic suppression of simple spikes.15,18 Therefore, harmaline is
thought to enhance the CF–PC synaptic transmission, which is
intrinsically oscillatory, to drive tremor.
Harmaline-induced tremor is predominantly action tremor13
(Figure 2) that responds to propranolol, primidone, and alcohol.19
Therefore, harmaline-induced tremor has long been postulated to be
an animal model of ET. Harmaline belongs to a group of naturally
occurring compounds, called b-alkaloids. In ET patient blood and
brain, increased harmaline-related b-alkaloids, such as harmane, have
been observed,20,21 suggesting that environmental factors may
contribute to oscillatory activities in the olivocerebellar system in ET
patients.
Figure 2. Characteristics of Harmaline-Induced Tremor in Mice. (A) A representative time-frequency plot of harmaline-induced mouse tremor, which
shows that harmaline can induce action tremor at the peak frequency around 13–15 Hz. The tremor was induced by a single intraperitoneal injection of harmaline
hydrochloride (Sigma) at 5 mg/kg into a WT C57BL/6J mouse, and the mouse tremor was measured using Convuls-1 sensing platform (Columbus Instruments), co-
registered with a video-based motion detection (NeuroMotive, BlackRock microsystem) to separate action vs. rest tremor. (B) The quantification of movement
intensity at different frequency, showing that tremor occurs at action but minimal at rest in harmaline-induced tremor mouse model.
Figure 1. Search Strategy. Flow diagram for the literature search results.
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Under the conceptual framework of oscillatory neuronal activities in
tremor, several modulatory agents that can influence the olivocer-
ebellum have been tested in this harmaline-induced tremor model
as pre-clinical studies for ET. For example, a gap junction blocker,
carbenoxolone, has been shown to effectively suppress harmaline-
induced tremor22 and T-type calcium channels that are important
for PC complex spikes can also suppress harmaline-induced tremor.23
Currently, a phase II randomized placebo-controlled clinical trial for a
T-type calcium channel blocker is underway for ET (clinicaltrials.gov:
NCT03101241), partly based on the understanding of the cerebellar
circuitry in harmaline-induced tremor.
While harmaline-induced tremor indicates the importance of the
connections between the IO neurons and PCs (Figure 3), animal model
studies suggest that other parts of the cerebellar system can also drive
oscillatory neuronal activities. For example, the gamma-aminobutyric
acid (GABA)-ergic deep cerebellar nuclei (DCN) send axons to IO
neurons, which may control the coupling between IO neurons. Loss
of this nucleo-olivary GABAergic control may result in enhanced
electrotonic coupling between IO neurons, leading to synchronized PC
complex spikes.24 Additionally, IO neurons also receive glutamatergic
inputs, which may modulate the synchronization of PC firing.25 These
regulatory components of the olivo-cerebellar system are likely to
determine the frequency and the strength of neuronal synchrony, and
potentially influence the presentation of tremor. In a post-mortem
study of ET patients, there was no evidence of IO neuronal loss,26
which might have allowed the olivocerebellum system to generate
rhythmic and synchronized neuronal activities, under the regulation of
the above-mentioned nucleo-olivary control, to drive tremor. Whether
ET patients exhibit alterations of these synaptic structures in IOs
requires further investigation.
Harmaline has been shown to induce action tremor in a wide variety
of animals, including mice,19,22,27 rats,19 cats,15 monkeys,28 and pigs,29
suggesting an evolutionarily conserved olivocerebellar circuit for
tremor generation. However, different species may have different
frequencies in harmaline-induced tremor (mice, 10–16 Hz; rats, 8–12
Hz; pigs, 8–12 Hz).19 Note that ET patients have tremor at 4–12 Hz.11
Interestingly, the chronic responses to harmaline also differ among
species. Repeated exposures to harmaline will induce ‘‘tolerance’’ in
rats and pigs, where the tremor decreases with repeat exposure. This
phenomenon presents an exception in mouse models, which tend to
develop robust tremor even with repeated harmaline injections.29,30
Neuropathological assessment between rats and mice with repeated
harmaline exposures showed that rats have extensive PC loss,31 which
may be due to excitotoxicity from overstimulation of CF synaptic
transmission onto PCs,31 whereas PCs in mice are relatively pre-
served.30 These results might indicate that preserved PCs may be
required for the continuous harmaline-induced tremor, which is
thought to generate from CF-driven synaptic activities. In ET patients,
moderate PC loss has also been identified.8,32 Whether the PC loss
in ET is due to the longstanding, abnormal excitatory synaptic
transmission or is a primary PC degenerative process requires further
investigation.
While harmaline-induced action tremor models present similarities
to ET, this model remains controversial. First, agents that can worsen
ET, such as valproate and lithium, tend to suppress harmaline-induced
action tremor;33 however, these tremor-suppressing effects might be
due to the non-specific reduction of motor activities because harmaline
induces predominantly action tremor. Further studies are required.
Second, harmaline is a toxin model and, as such, tremor amplitude
may be dose-dependent and further influenced by the timing of tremor
Figure 3. Brain Circuitry for Tremor. Schematics for the brain circuitry involved in the tremor of animal models. The brain circuitry alterations in each animal
model of tremor are highlighted. CF, Climbing Fiber; DCN, Deep Cerebellar Nucleus; IO, Inferior Olive; PC, Purkinje Cell; VL, Ventrolateral Nucleus of the Thalamus.
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assessment. Third, the rapid tolerance of harmaline in animals such as
rats and pigs present difficulty for large-scale drug screening. However,
the aforementioned animal models still have significant value for the
validation of specific agents.
Nonetheless, harmaline-induced action tremor models indicate that
the olivocerebellum is capable of generating action tremor and
neuronal rhythmicity and synchrony might underlie the pathophysiol-
ogy of tremor. Along these lines, the structural alterations that can lead
to neuronal synchrony and/or rhythmicity within the olivocerebellar
circuitry may contribute to tremor. For example, abnormal CF–PC
synaptic connections have been identified in post-mortem studies of
ET cerebellum. Specifically, CFs form synaptic connections with the
distal, spiny branchlets of PC dendrites, which should have been the
parallel fiber territory.9,34–37 This CF–PC synaptic pathology distin-
guishes ET from other cerebellar degenerative disorders.35 Further-
more, this CF–PC synaptic pathology may occur across different
subtypes of ET, regardless of age of tremor onset and family history of
tremor.9 The extension of CF synapses onto the parallel fiber synaptic
territory on PCs is likely to increase the influence of IO activities on
PCs, which might enhance the synchrony and rhythmicity in the
cerebellar circuitry.38,39 The other source of neuronal synchrony
within the cerebellar circuitry may occur at the level of downstream
of PC dendritic synapses. For example, PC axonal collaterals and
sprouting have been found in post-mortem studies of ET cerebellum,40
possibly in response to partial PC loss. It is possible that this PC axonal
sprouting process could set up rhythmicity and synchrony within the
cerebellar circuitry. Note that post-mortem studies of human patho-
logy need to be interpreted with caution. In particular, observations in
human studies cannot establish whether the structural changes are the
consequences of longstanding neuronal activities associated with tremor
or the primary causes for tremor. Detailed tremor measurements
and physiology studies in animal models with the above-mentioned
pathological alterations will likely provide further mechanistic insight.41
In addition, changes in ion channels and/or receptors have not been
extensively studied post-mortem in human brains affected by tremor,
which might shed light on the pathomechanism of tremor.
In summary, different levels of neuronal synchrony within the
cerebellar system are believed to set up the pathophysiological sub-
strate for tremor generation, which may partly explain the clinical
heterogeneity of ET.4
Animal models of rest tremor
Rest tremor is one of the cardinal features of PD. While dopamine
neuronal loss in the nigrostriatal system is the pathological hallmark of
PD,42 dopamine depletion in animals leads to bradykinesia, with rest
tremor not consistently reported in such models.43,44 The most
commonly used toxin to deplete dopamine terminals in mice is
6-hydroxydopamine (6-OHDA) injection into the striatum; this pro-
cedure can infrequently induce rest tremor.44 Even in mice models
with 6-OHDA-induced rest tremor, tremor is usually not a prominent
feature. It is currently unknown why some mice develop rest tremor
while others don’t. Detailed mechanistic studies are required.
The early work for rest tremor comes from studies in monkeys:
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated vervet
(African green) monkeys develop robust rest tremor while MPTP-
treated rhesus (Macaca mulatta) monkeys have only very infrequent rest
tremor.43 The rest tremor in vervet monkeys is approximately 5–7 Hz,
measured using an accelerometer, with corresponding synchronous
firing of pallidal neurons. This tremor is very similar to that in PD
patients.43 Detailed neuropathological studies comparing these two
types of MPTP-treated monkeys found that vervet monkeys have more
affected dopamine neurons in the retrorubral area, whereas rhesus
monkeys have more profound dopamine neuronal loss in the sub-
stantia nigra pars compacta.45–47 The retrorubral dopamine system
has preferential projection to the pallidum, suggesting that pallidal
dopamine might play a role in rest tremor generation,48 which is
consistent with recent findings in human functional magnetic
resonance imaging (fMRI) studies.7,49 However, there are few studies
focusing on the anatomy and functions of the pallidal dopamine
pathway, and its role in tremor generation remains largely unknown.
Further comparisons of the neuropathology and physiology between
animal models will lead to a better understanding of the mechanism
of rest tremor.
Recent advancement of knowledge of rest tremor comes from
human neuroimaging studies7,49 which demonstrate that the interac-
tion between the basal ganglia and the cerebellum is important for rest
tremor generation. Specifically, the ‘‘dimmer-switch’’ model proposes
that the basal ganglia initiate tremor whereas the cerebellum modu-
lates tremor amplitude and rhythmicity50 (Figure 3). The involvement
of the cerebellum system is further supported by the effectiveness of
deep-brain stimulations in the region of the thalamus that receives
cerebellar output both in 6-OHDA-treated mice with rest tremor44
and in PD patients.51 Another evidence of the cerebellar involve-
ment in rest tremor is that PD patients have hyper-metabolism in
the cerebellum based on the positron emission tomography (PET).52
Whether this hypermetabolism in the cerebellum has a structural basis
or merely reflects functional neuronal activities remains to be studied.
Intriguingly, a study recently found abnormal CF–PC synaptic
organization and other PC pathology in post-mortem brain studies
of PD cases with rest tremor,35 which may suggest that structural
changes in the cerebellum contribute to rest tremor. The detailed
mechanism of how the interaction between the basal ganglia and the
cerebellum generates rest tremor requires further studies in animal
models to test the causal relationship between structural alterations in
the brain circuitry and tremor.
Other tremor animal models with quantitative tremor
measurement
Recently, several quantitative studies of novel animal models have
been performed. However, it is unclear whether these animals have
predominantly action tremor or rest tremor. Therefore, we have
included these animal models and the related pathophysiology in this
section.
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A recent discovery of tremor of Waddles (wdl) mice, which have
spontaneous mutations in the Car8 gene,53 has greatly advanced our
understanding of tremor in animal models. CAR8 protein is pre-
dominantly expressed in PCs and the loss-of-function mutation of Car8
in wdl mice results in tremor of 5–15 Hz. wdl mice have altered
frequency and regularity of simple spike and complex spikes of PCs,
which likely underlie the physiology of tremor. Another interesting
feature of wdl mice is the disturbance of the microzonal organization
of the cerebellum. The cerebellar circuitry has been organized in
the microzones, for which there are specific sets of CF–PC–DCN
connections that govern motor control.54 The afferent inputs to the
cerebellum, mossy fibers, also follow such microzonal rules. The micro-
zones of the cerebellum could be traced by a set of PC markers, such as
zebrin II or excitatory amino acid transporter type 4 (EAAT4).55,56
The disturbance of microzonal organization within the cerebellum
may cause improper neuronal signaling, leading to tremor. It remains
to be studied in detail how this altered PC firing in the context of
microzonal organization can lead to tremor in wdl mice. Further post-
mortem studies in microzonal organization of tremor disorders using
the human brain will test the relevance of such findings in patients.
Nonetheless, mutations of Car8 have been found in patients with
tremor and ataxia,57,58 which further contribute to the translational
aspect of this mouse model and human disorders.
One of the main hypotheses of tremor generation is PC loss,8,32
which may potentially be modeled by the recent identification of the
Shaker rat. This natural mutant rat develops low-frequency tremor of
around 5 Hz; the predominant pathology of this rat is PC loss,
particularly in the anterior lobe of the cerebellum.59 Interestingly, the
tremor is present at the stage of mild to moderate PC loss whereas
the Shaker rats eventually develop frank ataxia with severe PC loss,
indicating that tremor might arise in the intermediate stage of PC
degeneration.60 However, if partial PC loss is sufficient to cause
tremor, one would expect to observe tremor in the early stage of here-
ditary ataxias with PC degeneration such as spinocerebellar ataxias
(SCAs). However, tremor only occurs in a minor subset of SCA
patients.61 Within the common types of SCAs, SCA2 often has tremor
when compared with SCA1 and SCA6.61 Therefore, further
comparisons of varied subtypes of SCAs with PC degeneration might
provide further insight into the pathophysiology of tremor.
Another hypothesis for tremor states that GABA deficiency within
the cerebellar circuitry leads to enhanced pacemaking neuronal
activities.62 This hypothesis originated from the observation of a
subset of ET patients who responded to GABAergic medications, such
as primidone and alcohol.63,64 Relevant to this clinical observation, a
moderate decrease in GABA receptors has been identified post-
mortem in the ET dentate nucleus.65 Along these lines, knockout mice
with GABAA receptor a1 subunit deficiency have been found to
develop tremor that is responsive to propranolol and primidone.66
However, the detailed physiological alterations in dentate neurons and
PCs in the freely moving GABAA receptor a1 subunit knockout mice
still need to be determined, and whether this mouse model has
predominant rest or action tremor requires further investigation.
The aforementioned mouse model has some unique characteristics
that are distinct from those of ET patients. First, diazepam, a medi-
cation than may lessen tremor in ET patients,63 can dramatically
enhance tremor in this mouse model. The GABAA receptor a1 subunit
knockout mice have a 15–19 Hz tremor,66 which is at a significantly
higher frequency than that in ET patients.11 Third, a recent neuro-
imaging finding showed that ET patients do not have obvious GABA
deficiency in the dentate nucleus,67 which questions the relevance of
this mouse model to ET in humans. Another possibility is that GABA
deficiency in ET patients occurs outside the dentate nucleus, such as in
the thalamic nucleus68 or IO neurons,24 which might cause oscillatory
neuronal activities and tremor. Alcohol responsiveness remains a
phenomenon of interest in studies of ET. While this mouse model does
not possess the GABAA receptor a1 subunit, mouse tremor can be
suppressed by alcohol, indicating that an alternative factor, such as
different subtypes of GABA receptors, might be responsible for this
tremor-suppression effect. Future studies on the neuronal population-
specific GABAA receptor a1 subunit knockout will advance our under-
standing of the role of GABAergic synaptic transmission in tremor.
Animal models of tremor with less defined tremor measurement
In our extensive literature search, we found that animal models of
tremor could be divided into two broad categories: chemical- or lesion-
induced (Table 2), or based on genetic mutations (Table 3). However,
tremor is usually not the primary interest of these published animal
models, and tremor frequency and amplitudes are less defined than in
the above-mentioned animal models. In addition, for those with
objective tremor measurement, confirmatory studies are needed to
better delineate these tremor phenotypes. Moreover, ataxia and
tremor are two symptoms related to cerebellar dysfunction. Ataxia is
associated with motion irregularity, whereas tremor is movement with
defined frequency and rhythm. Therefore, detailed measurement of
frequency and variability of motions in animal models should enhance
understanding of the brain circuitry for ataxia and tremor.
In chemically induced animal models of tremor69–81 (Table 2), we
found that agents working on the cholinergic axis are able to induce
tremor. For example, agents that promote the cholinergic nervous
system, such as oxotremorine,70 arecoline,70 nicotine,75 pilocarpine,72
and physostigmine,74 can produce tremor in rodents. Interestingly,
promoting muscarinic (oxotremorine), nicotinic (arecoline, pilocarpine,
and nicotine), or both (physostigmine) types of cholinergic receptor
systems can produce tremor, but whether the tremor characteristics
differ in these animal models requires further investigation. One of the
clinical implications is that rest tremor in PD can be treated with
anticholinergics;82 therefore, rest tremor may be associated with a
hypercholinergic state. Further investigation is needed.
In lesion-induced animal models of tremor, we found that cerebellar
lesions could produce tremor81 and/or change the frequency of
physiological tremor80 in monkeys, highlighting the contribution of the
cerebellum to tremor (Table 2).
Finally, there is a list of animal models of tremor with different
genetic mutations83–103 (Table 3). Most of the tremor measurements in
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these animal models are based on observation only and require
objective assessment to delineate rest and action tremor, which are the
defining features for human tremor disorders. Many of these genetic
tremor animal models have a dysfunctional cerebellar circuit (Table 3).
The genetic models provide an invaluable resource for stable tremor
phenotypes. Additionally, tremor in some of the models is regulated
developmentally and throughout adulthood, which can be further
studied to understand the role of aging in the underlying neuropathol-
ogy and physiology.
The relevant knowledge learned from animal models in the
context of controversies in the tremor field
Animal models of tremor allow researchers to perform detailed
physiological studies and brain circuitry dissections using optogenetic
tools or electric stimulations. Therefore, animal models can be
considered as tools to understand tremor disorders. In the present
paper we posit a question: ‘‘How do animal models of tremor help us
to move towards a better understanding of the current controversies in
Table 2. Chemical- or Lesion-induced Animal Models of Tremor
Chemical/Lesion Tremor Type and Frequency (Hz) Tremor Measurement Reference
Mouse Harmaline-induced 10–16 Hz body tremor Force plate-based measurement 19
6-OHDA-induced 4–5 Hz body tremor Electromyography or force
plate-based measurement
44
Galantamine-induced Oral tremor (3–7.5 Hz frequency





Tremor Multiple electrical physiological
signals real-time analyzer
70
Phenol-induced Tremor Observation 71
Pilocarpine-induced Oral tremor Observation 72
Rat Harmaline-induced 8–12 Hz body tremor Force plate-based measurement 19




Tremor(6–7 Hz)tremor (11–13 Hz)
tremor (peak of 13 Hz)
Objective measure, not detailed in
method
74
Nicotine-induced Tremor Observation 75
p-Chloroamphetamine-induced Tremor Observation 76
p,p’-DDT-induced Tremor Observation 77
Tacrine-induced Oral tremor Observation 78
Monkey MPTP-induced 5–7 Hz limb tremor Accelerometer 43
Electrical coagulation of the
brainstem area including the
substantia nigra and the red
nucleus
Resting tremor (stable frequency
of 4.46 ¡ 0.59 Hz)
An accelerometer connected
to a computer system
79
Repeated electrode penetration of
the dentate and interpositus nuclei
Change the physiological tremor





Abbreviations: EMG, Electromyography; DCN, Deep Cerebellar Nucleus.
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the tremor field?’’ To answer this question, we will discuss two major
controversies in the tremor field: 1) the relationship between tremor
and dystonia, 2) the relationship between ET and PD.
Many ET patients have co-existing dystonic features.4 It remains
unclear whether dystonia and tremor are generated from the same or
different sources in ET patients with dystonic features. Therefore, we
reviewed the literature in animal models, and aimed to find a similarity
between tremor and dystonia. Interestingly, both tremor and dystonia
could originate from the dysfunctional cerebellum. From a harmaline-
induced tremor model, PC rhythmic firing could drive real-time
rhythmic motor activities (i.e., tremor).15 In mouse models with viral-
mediated DYT1 or DYT12 knockdown in the cerebellum, dystonia
may be induced, with a corresponding increased burst firing of
PCs.104–106 These studies suggest that real-time abnormalities of PC
firing might lead to involuntary movements, which has also been
demonstrated by artificially driving PC activities using optogenetics.107
Therefore, abnormal PC firing may be a common neurophysiological
underpinning for tremor and a subset of dystonia. Abnormal PC firing
could be at times rhythmic and at times high-frequency, burst firing
depending on the different stages of the disease process, and these
abnormal PC firing patterns may be temporally and spatially
segregated within the cerebellar cortex. This can lead to overlapping
tremor and dystonia symptoms in different body regions and/or hand
positions. Within this framework, the dystonic feature in a subset of ET
patients might originate in the cerebellar region. Future studies of
different animal models of tremor and dystonia should help to settle
this controversy.
The overlapping of symptoms between ET and PD remains
controversial. According to epidemiological studies, ET patients have
a fivefold increased risk for PD, and these PD patients are often the
tremor-predominant type.108,109 Severe ET patients will have rest
tremor,108 whereas PD patients often have postural and/or action
tremor.110 It is possible that overlap between ET and PD occurs at the
brain circuitry level. As mentioned above, the structural changes in the
ET cerebellum may generate oscillatory neuronal activities to drive
tremor. In PD, dopamine deficiency may cause infrequent tremor,
but the structural changes in the cerebellum can amplify this tremor.
This dopamine deficiency associated with rest tremor might be at the
level of the globes pallid us internal or the ventrolateral thalamus based
on human fMRI studies.7,111 A recent study found abnormal CF–PC
synaptic connections in the cerebellum of both ET and PD patients,35
possibly demonstrating common brain circuitry abnormalities in these
two disorders (Figure 3). This concept is further supported by evidence
of the ability of harmaline to intensify rest tremor in monkeys.28 Future
studies in animal models should aim to simulate structural changes
in the cerebellar circuits and the dopamine system in ET and PD,
respectively, such studies should help decode this pathomechanism.
Conclusions
The use of animal models in tremor research is an emerging field.
As we begin to comprehensively understand tremor disorders based on
genetic, neuroimaging, and neuropathological studies in humans,
modeling these genetic and pathological alterations in animal models
will greatly advance our understanding of how tremor is generated.
Established animal models are likely to provide an important platform
to screen therapies for tremor disorders.
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